{
  "retracted": false,
  "timestamp": 1372636800000,
  "updates": [
    {
      "timestamp": 1496012939646,
      "identifier": {
        "doi": "10.1016/j.ygyno.2013.04.007"
      },
      "type": "err"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.ygyno.2012.08.020"
  },
  "journal": "Gynecologic Oncology",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study” [Gynecol Oncol 127 (2012) 538–543]"
}
